MedTrace Logo

Clindamycin Versus Amoxicillin With Clavulanic Acid in Prevention of Early Dental Implants Failure

NCT04980170 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-07-28

No results posted yet for this study

Summary

Among patients receiving dental implants, does the choice of antibiotics reduce the frequency of early implant failure ?

Conditions

  • Antibiotics Causing Adverse Effects in Therapeutic Use

Interventions

DRUG

Clindamycin 300 mg

patients will be given clindamycin 300 mg twice daily for 5 days after dental implant

DRUG

Amoxicillin with Clavulanic Acid 635mg

patients will be given Amoxicillin with Clavulanic Acid 635mg, three times daily for 5 days after dental implant

Sponsors & Collaborators

  • Jordan University Hospital

    lead OTHER

Principal Investigators

  • ASHRAF ABUKARAKI, PROFESSOR · Jordan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-03-15
Completion
2022-06-01

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04980170 on ClinicalTrials.gov